X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FWBI

Closed

First Wave Biopharma Inc

2.07
+2.07 (0%)
Last Update: 14 Jun 2024 16:30:00
Yesterday: 0.
Day's Range: 2.05 - 2.29
Send
When Written:
 
2.68
First Wave BioPharma Inc is a clinical-stage biotechnology company that develops novel therapies for the treatment of cancer and other serious diseases. The company's lead product candidate, FW-1022, is a targeted therapy for the treatment of triple-negative breast cancer, a highly aggressive form of the disease. The drug is designed to selectively target cancer cells while sparing healthy cells, thereby reducing the side effects associated with traditional chemotherapy.

First Wave BioPharma was founded in 2016 and is headquartered in San Diego, California. The company is led by a team of experienced biotech executives and has partnerships with leading academic institutions and research organizations. First Wave BioPharma is focused on advancing its pipeline of innovative therapies through clinical development and regulatory approval.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X